0001193125-19-114133.txt : 20190423 0001193125-19-114133.hdr.sgml : 20190423 20190423070532 ACCESSION NUMBER: 0001193125-19-114133 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20190423 DATE AS OF CHANGE: 20190423 EFFECTIVENESS DATE: 20190423 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sierra Oncology, Inc. CENTRAL INDEX KEY: 0001290149 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37490 FILM NUMBER: 19760628 BUSINESS ADDRESS: STREET 1: 2150 ? 885 WEST GEORGIA STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 BUSINESS PHONE: 604-558-6536 MAIL ADDRESS: STREET 1: 2150 ? 885 WEST GEORGIA STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 FORMER COMPANY: FORMER CONFORMED NAME: ProNAi Therapeutics Inc DATE OF NAME CHANGE: 20040513 DEFA14A 1 d732747ddefa14a.htm DEFINITIVE ADDITIONAL MATERIALS Definitive Additional Materials

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

SCHEDULE 14A

(Rule 14a-101)

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

 

 

Filed by the Registrant  ☒                             Filed by a Party other than the Registrant  ☐

Check the appropriate box:

 

  Preliminary Proxy Statement
  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
  Definitive Proxy Statement
  Definitive Additional Materials
  Soliciting Material Pursuant to §240.14a-12

SIERRA ONCOLOGY, INC.

(Name of Registrant as Specified In Its Charter)

N/A

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

  No fee required.
  Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
  1)  

Title of each class of securities to which transaction applies:

 

     

  2)  

Aggregate number of securities to which transaction applies:

 

     

  3)  

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

     

  4)  

Proposed maximum aggregate value of transaction:

 

     

  5)  

Total fee paid:

 

     

  Fee paid previously with preliminary materials.
  Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
  1)  

Amount Previously Paid:

 

     

  2)  

Form, Schedule or Registration Statement No.:

 

     

  3)  

Filing Party:

 

     

  4)  

Date Filed:

 

     

 

 

 


*** Exercise Your Right to Vote ***

Important Notice Regarding the Availability of Proxy Materials for the

Stockholder Meeting to Be Held on June 11, 2019.

 

 

 
 

SIERRA ONCOLOGY, INC.

 

 

 

 

SIERRA ONCOLOGY, INC.

C/O 2150-885 WEST GEORGIA STREET

VANCOUVER, BC V6C 3E8

CANADA

 

 

 

LOGO

      
 

 

Meeting Information

 

 

Meeting Type:         Annual Meeting

 

For holders as of:    April 15, 2019

 

Date:  June 11, 2019           Time: 10:00 AM PT

 

Location:    Four Seasons Hotel Vancouver

                     791 West Georgia Street

                     Vancouver, BC V6C 2T4

                     Canada

 

 

 

You are receiving this communication because you hold shares in the company named above.    

 

This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).

 

We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

 

See the reverse side of this notice to obtain proxy materials and voting instructions.

 


— Before You Vote —

How to Access the Proxy Materials

 

 

 

Proxy Materials Available to VIEW or RECEIVE:

   
  NOTICE AND PROXY STATEMENT   FORM 10-K
   
  How to View Online:    
 
  Have the information that is printed in the box marked by the arrow LOGO (located on the following page) and visit: www.proxyvote.com.
 

 

How to Request and Receive a PAPER or E-MAIL Copy:

 

 

If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:

 
 

1) BY INTERNET:       www.proxyvote.com

2) BY TELEPHONE:   1-800-579-1639

3) BY E-MAIL*:           sendmaterial@proxyvote.com

 
 

*  If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow LOGO (located on the following page) in the subject line.

 

 

Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before May 28, 2019 to facilitate timely delivery.

 

— How To Vote —

Please Choose One of the Following Voting Methods

 

 

LOGO

 

 

 

Vote In Person: Many stockholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.

 

Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow LOGO (located on the following page) available and follow the instructions.

 

Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.

 


  Voting Items   

 

  The Board of Directors recommends you vote FOR Proposal 1:
  1.   Election of Class I Directors    
    Nominees:    
    01)    Jeffrey H. Cooper    
    02)    Tran Nguyen    
  The Board of Directors recommends you vote FOR Proposal 2:
  2.   To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2019.
  NOTE: In their discretion, the proxies are authorized to vote upon such other business as may properly come before the annual meeting or any adjournment thereof.

 

LOGO

          


 

 

 

 

 

 

LOGO

 
GRAPHIC 2 g732747g71u90.jpg GRAPHIC begin 644 g732747g71u90.jpg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end GRAPHIC 3 g732747img02.jpg GRAPHIC begin 644 g732747img02.jpg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g732747img03.jpg GRAPHIC begin 644 g732747img03.jpg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g732747img04.jpg GRAPHIC begin 644 g732747img04.jpg M_]C_X0 817AI9@ 24DJ @ /_L !%$=6-K>0 ! 0 !D M #_X0-V:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@ M8F5G:6X](N^[OR(@:60](EG)E4WI.5&-Z:V,Y9"(_/B \ M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)! M9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ-#4V-C$L(#(P,3(O,#(O,#8M M,30Z-38Z,C<@(" @(" @("(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO M+W=W=RYW,RYO7!E+U)E&UL M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(B!X;7!-33I/ M&UP34TZ1&5R:79E9$9R;VT@'!A8VME="!E;F0](G(B/S[_[@ .061O8F4 M9, !_]L A ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! @(" @(" @(" @(# P,# P,# P,# 0$! 0$! 0(! 0(" @$" M @,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# M P,# P/_P 1" !* @# 1$ A$! Q$!_\0 <@ @,! M!P@"!@D* 0$! 0 @$0 (" P$ 0(%!0 4& M! <" P@!$@ 1(34W"3D3,U-E:!$ @(!! (# $1(3'P06%Q M@0*A(I+_V@ , P$ A$#$0 _ .G?C&MJEFTQ5P;D#K3%,L=/KE)\L%46-Q)M MJ]N+:PXC67=6#G"WM()K6 [Q,UYS-)<#BGRRODCS?E)W>9?B+;<_94!W&[:= M9:;J5#V<@2G#33G+@KI"OCKY=*8KV>M\?)0D8/7[,5+0KZ+*:ENY#46)KQS7 M8N\%#QVXYXR#.G7[]O1L--WO\@S;Q$$WX&0"//1"NKJ1*R7K-SK=7_;]UN*' M>7:FF8Q"[#U-5@ZZR-U_HK$Q*$"=PV<)9 T64+-[Y4DGAE ST11O,UWL/50& M)"X9)9<&?N-=+NS<"V%3V4P75%'UTL-J-M;2XL S(F;GRIY!?5B/HC:A\TTO M$28K9/P]SU[M>$B/CZ(=7%:Y(2.+AE76/S\N)MK]8Z5..IN57C6S&_A\*#5* MD)&*IE:0A@@DH2MI^(WRE&'%U8>[,I>G4*\R^>6/F?W&S*>!,AW.?!K>YC3] M4MU6.=,50Q%^B+%"VI M[RSA%8JH%RV&6NE7$O%]*WM44@U-T_TI?P)Q(GQ^ MT4WOUY11WT*GVB\AP@G:0MSD.E$CH^@+E1@0X,)4E =^>!O+9 MA-P]T1_-01Z]V O1#$QJT6&59.-K/J!7XH5AM7WP\Y6C)N"IJ.3LF>:!Z02 M*YT(!6$,L&2MDXVPG)%,XB03+K8^7KSB8XXQ-(U- GRAPHIC 6 g732747newimg01.jpg GRAPHIC begin 644 g732747newimg01.jpg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